VitaNova Life Sciences Corp (VNOV) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2023 | $8.7K | -62.2% |
| 2022 | $23.1K | — |
| 2021 | $0 | — |
| 2020 | $0 | — |
| 2019 | $0 | -100.0% |
| 2018 | $4.4K | +2056.6% |
| 2017 | $205 | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2023 | $8.7K | -62.2% |
| 2022 | $23.1K | — |
| 2021 | $0 | — |
| 2020 | $0 | — |
| 2019 | $0 | -100.0% |
| 2018 | $4.4K | +2056.6% |
| 2017 | $205 | — |